Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM)
Clinical trial NCT01651039 · COMPLETED
Trial details
- NCT number
- NCT01651039
- Sponsor
- Ajai Chari
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2016-12-21
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.